These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4287801)

  • 41. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 43. The problem of the chronic excretor of tubercle bacilli.
    Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K
    Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247
    [No Abstract]   [Full Text] [Related]  

  • 44. Tubercle bacilli resistance to cycloserine.
    Zierski M; Rózewska M; Woźniak S
    Scand J Respir Dis Suppl; 1970; 71():291-5. PubMed ID: 4989519
    [No Abstract]   [Full Text] [Related]  

  • 45. [Cross-resistance of tubercle bacilli (a review) (III) (author's transl)].
    Tsukamura M
    Kekkaku; 1977 Apr; 52(4):171-5. PubMed ID: 69737
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug resistance of tubercle bacilli -- from the clinical point of view (author's transl)].
    Fukuhara Y
    Kekkaku; 1976 Dec; 51(12):477-87. PubMed ID: 65494
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on resistance of tubercle bacilli to reserve drugs. II. Resistance to viomycin and kanamycin in experimenta tuberculosis in guinea pigs].
    Janowiec M
    Gruzlica; 1966 Oct; 34(10):903-6. PubMed ID: 4292274
    [No Abstract]   [Full Text] [Related]  

  • 48. [Anti-bacterial activity of capreomycin, kanamycin, or viomycin against drug-resistant tubercle bacilli isolated from patients].
    Endo K
    Jpn J Antibiot; 1971 Jun; 24(3):149-51. PubMed ID: 4327336
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cross-resistance relationship among capreomycin, kanamycin, viomycin and streptomycin resistance of Mycobacterium tuberculosis].
    Tsukamura M; Toyama H; Mizuno S; Tsukamura S
    Kekkaku; 1967 Oct; 42(10):399-404. PubMed ID: 4295935
    [No Abstract]   [Full Text] [Related]  

  • 50. The 7H11 medium for the cultivation of mycobacteria.
    Cohn ML; Waggoner RF; McClatchy JK
    Am Rev Respir Dis; 1968 Aug; 98(2):295-6. PubMed ID: 4299186
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cross resistance of Mycobacterium tuberculosis to streptomycin, kanamycin and viomycin].
    Makarevich NM; Mkrtchian SV; Afanas'eva IuP
    Antibiotiki; 1970 Apr; 15(4):345-51. PubMed ID: 4321321
    [No Abstract]   [Full Text] [Related]  

  • 52. [Criteria of mycobacterium resistance to thioacetazone and cross resistance to ethionamide].
    Afanas'eva IuP; Mkrtchian SV
    Probl Tuberk; 1969; 47(3):66-9. PubMed ID: 4982181
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on lividomycin. I. In vitro antibacterial activities of LVDM against clinical isolates of Mycobacterium tuberculosis.
    Shimizu T
    Jpn J Antibiot; 1974 Dec; 27(6):766-74. PubMed ID: 4142798
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparative study of the susceptibility to ethionamide and isoniazid of tubercle bacilli from patients never treated with ethionamide.
    Hok TT; Seng TK
    Paediatr Indones; 1967; 7(1):32-8. PubMed ID: 4963150
    [No Abstract]   [Full Text] [Related]  

  • 56. [Antimycobacterial activity of ethionamide on the tubercle bacilli in a semisolid Dubos agar medium].
    Okamoto K; Terunuma K
    Kekkaku; 1967 Dec; 42(12):489-94. PubMed ID: 4970608
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on media for testing resitance to cycloserine. 4. Various lots of cycloserine and the minimal inhibitory concentration to Mycobacterium tuberculosis].
    Tamura M; Takano S
    Iryo; 1967 May; 21(5):550-2. PubMed ID: 4965697
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dihydrostreptomycin as a factor inducing L-forms in Mycobacterium tuberculosis].
    Dorozhkova IR; Volk AV
    Antibiotiki; 1972 Oct; 17(10):915-22. PubMed ID: 4121154
    [No Abstract]   [Full Text] [Related]  

  • 59. [Conditions for ethionamide activity and the formation of resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1979 Oct; (10):58-60. PubMed ID: 41236
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.